MRI assessment of cerebral perfusion in clinical trials

X Wang, C Bishop, J O'Callaghan, A Gayhoor… - Drug Discovery …, 2023 - Elsevier
Highlights•Use of MRI perfusion imaging in clinical trials and as an alternative to other
imaging modalities.•Detailed description of imaging procedures, best practices in clinical …

Recent advances in arterial spin labeling perfusion MRI in patients with vascular cognitive impairment

D Huang, Y Guo, X Guan, L Pan, Z Zhu… - Journal of Cerebral …, 2023 - journals.sagepub.com
Cognitive impairment (CI) is a major health concern in aging populations. It impairs patients'
independent life and may progress to dementia. Vascular cognitive impairment (VCI) …

Association of intensive vs standard blood pressure control with cerebral blood flow: secondary analysis of the SPRINT MIND randomized clinical trial

S Dolui, JA Detre, SA Gaussoin, JS Herrick… - JAMA …, 2022 - jamanetwork.com
Importance Antihypertensive treatments benefit cerebrovascular health and cognitive
function in patients with hypertension, but it is uncertain whether an intensive blood pressure …

[HTML][HTML] Arterial spin labeling versus 18F-FDG-PET to identify mild cognitive impairment

S Dolui, Z Li, IM Nasrallah, JA Detre, DA Wolk - NeuroImage: Clinical, 2020 - Elsevier
Neurodegenerative biomarkers support diagnosis and measurement of disease progression
in the Alzheimer's disease (AD) continuum. 18 F-Fluorodeoxyglucose Positron Emission …

Recommendations for quantitative cerebral perfusion MRI using multi‐timepoint arterial spin labeling: Acquisition, quantification, and clinical applications

JG Woods, E Achten, I Asllani, DS Bolar… - Magnetic resonance …, 2024 - Wiley Online Library
Accurate assessment of cerebral perfusion is vital for understanding the hemodynamic
processes involved in various neurological disorders and guiding clinical decision‐making …

[HTML][HTML] Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudo-progression in treated gliomas

A Pellerin, M Khalifé, M Sanson… - European …, 2021 - Springer
Objectives The aim of this work was investigating the methods based on coupling cerebral
perfusion (ASL) and amino acid metabolism ([18 F] DOPA-PET) measurements to evaluate …

[HTML][HTML] Detection of ictal and periictal hyperperfusion with subtraction of ictal-interictal 1.5-Tesla pulsed arterial spin labeling images co-registered to conventional …

K Abe, T Shimogawa, N Mukae, K Ikuta… - Surgical Neurology …, 2023 - ncbi.nlm.nih.gov
Background: Our recent report showed that 1.5-T pulsed arterial spin labeling (ASL)
magnetic resonance (MR) perfusion imaging (1.5-T Pulsed ASL [PASL]), which is widely …

Analysis of costs for imaging-assisted pharmaceutical intervention in Alzheimer's disease with lecanemab: Snapshot of the first 3 years

J Perron, C Scramstad, JH Ko - Journal of Alzheimer's …, 2023 - journals.sagepub.com
Background: The approval of lecanemab for the treatment of Alzheimer's disease (AD) by
the Food and Drug Administration in the United States has sparked controversy over issues …

Prospective longitudinal perfusion in probable Alzheimer's disease correlated with atrophy in temporal lobe

TD Zhou, Z Zhang, A Balachandrasekaran… - Aging and …, 2024 - pmc.ncbi.nlm.nih.gov
Reduced cerebral blood flow (CBF) in the temporoparietal region and gray matter volumes
(GMVs) in the temporal lobe were previously reported in patients with mild cognitive …

Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia

CA Morgan, TR Melzer, RP Roberts, K Wiebels… - Scientific reports, 2021 - nature.com
Cerebral blood flow (CBF) measured with arterial spin labelling (ASL) magnetic resonance
imaging (MRI) reflects cerebral perfusion, related to metabolism, and arterial transit time …